Vaccines, blood, antisera, toxins and cultures in   Portugal

Exports In 2023, Portugal exported $78.5M in Vaccines, blood, antisera, toxins and cultures, making it the 45th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 211th most exported product in Portugal. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Portugal are: Poland ($27.8M), Hungary ($13.8M), Germany ($7.59M), Angola ($6.61M), and South Korea ($6.47M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Portugal between 2022 and 2023 were Poland ($26.6M), Hungary ($12.8M), and Lithuania ($513k).

Imports In 2023, Portugal imported $959M in Vaccines, blood, antisera, toxins and cultures, becoming the 37th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 13th most imported product in Portugal. Portugal imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($211M), Netherlands ($174M), Germany ($172M), Switzerland ($97.2M), and South Korea ($82.7M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Portugal between 2022 and 2023 were South Korea ($62.2M), Netherlands ($54M), and Switzerland ($25.1M).